DOSSIER · 13F Holders · Q2 2026
BIOCRYST PHARMACEUTICALS INC
5 institutions still hold BIOCRYST PHARMACEUTICALS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 09058V953·5 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
5 institutions reported BIOCRYST PHARMACEUTICALS INC in Q2 2026. IMC-Chicago, LLC leads at 41.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.